BerandaALK-B • CPH
add
ALK-Abello A/S
Tutup sebelumnya
kr 202,20
Rentang hari
kr 203,20 - kr 207,00
Rentang tahun
kr 130,70 - kr 237,60
Kapitalisasi pasar
41,57Â M DKK
Volume Rata-Rata
214,88Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Berita pasar
NDAQ
1,76%
2,38%
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (DKK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,73Â M | 15,61% |
Biaya operasional | 793,00Â jt | 6,02% |
Penghasilan bersih | 266,00Â jt | 56,47% |
Margin laba bersih | 15,35 | 35,36% |
Penghasilan per saham | 1,20 | 50,00% |
EBITDA | 400,00Â jt | 40,35% |
Tarif pajak efektif | 32,32% | — |
Neraca
Total aset
Total liabilitas
| (DKK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,24Â M | 110,53% |
Total aset | 9,06Â M | 9,84% |
Total liabilitas | 2,61Â M | -9,08% |
Total ekuitas | 6,44 M | — |
Saham yang beredar | 221,56 jt | — |
Harga terhadap nilai buku | 6,95 | — |
Tingkat pengembalian aset | 11,32% | — |
Tingkat pengembalian modal | 14,70% | — |
Arus Kas
Perubahan kas bersih
| (DKK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 266,00Â jt | 56,47% |
Kas dari operasi | 722,00Â jt | 59,38% |
Kas dari investasi | -126,00Â jt | 88,35% |
Kas dari pembiayaan | -24,00Â jt | -103,67% |
Perubahan kas bersih | 574,00Â jt | 1.639,39% |
Arus kas bebas | -136,62Â jt | 81,76% |
Tentang
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
Didirikan
1923
Situs
Karyawan
2.613